Visual Outcomes of Ranibizumab Versus Bevacizumab in Diabetic Retinopathy: An Analytical Study. (PubMed, Nepal J Ophthalmol) - Oct 15, 2026 - "Both anti-VEGF agents were effective and safe in diabetic retinopathy; however, ranibizumab demonstrated superior efficacy, faster response, and shorter treatment duration, reinforcing its value for improving both clinical and patient-centred outcomes."
Clinical • Journal • Diabetic Retinopathy • Ophthalmology • Retinal Disorders
|
|
Ayushi Ramesh Devagekar; Rehanbaig Shamshirbaig Jamadar; Revanasiddappa Devarinti; Shreya Santosh Mote
|